Saturday, September 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 26, 2026

AGNC (AGNC) Q2 2025 Earnings Call Transcript

View original at finance.yahoo.com
AGNC (AGNC) Q2 2025 Earnings Call Transcript Image source: The Motley Fool. Date Tuesday, July 22, 2025 at 8:30 a.m…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Marginal investments are expected to generate high teens returns, somewhere between 18% to 20%

    80% confidence
  • Net spread and dollar roll income expected in range of mid- to high $0.30s to low to mid-$0.40s per share

    80% confidence
  • The outlook improved in Q2 2025 due to manageable MBS supply, growing MBS demand, stabilizing spreads at cheap levels, and cautious GSE reform approach

    80% confidence
  • AGNC has no plans to grow for the sake of growing; growth is tied to accretive capital raising

    80% confidence
  • The U.S. government will maintain implicit guarantees for Fannie Mae and Freddie Mac during privatization

    80% confidence
  • Expected MBS net supply for 2025 is approximately $200 billion at the low end of forecasts

    80% confidence
  • GSE privatization must not widen mortgage spreads and should potentially tighten them

    80% confidence
  • Federal Reserve quantitative tightening expected to end relatively soon, possibly through year-end 2025

    80% confidence
  • GSE reform will follow a do-no-harm approach with no upward pressure on mortgage rates

    80% confidence
  • AGNC has the lowest operating costs in the industry at 111 basis points

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com